Product image of Niquitin Mint (Nicotine Resinate) supplied by GNH India

Niquitin Mint

Active Ingredient:
Nicotine Resinate
Origin:
EU

Niquitin Mint (Nicotine Resinate)

Nicotine resinate, the active ingredient in Niquitin Mint, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It is intended to aid adults who wish to quit smoking by reducing nicotine withdrawal symptoms.

GNH India supplies Niquitin Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, adhering to stringent quality standards and providing regulatory‑approved batches to meet global demand.

Manufacturer / TM Owner

Omega Pharma Portuguesa Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Niquitin Mint is a nicotine replacement therapy used in the management of nicotine dependence and smoking cessation.

  • Smoking cessation: helps adults reduce cravings and withdrawal symptoms when quitting tobacco.
  • Nicotine dependence: provides controlled nicotine delivery to support gradual reduction of nicotine intake.

How It Works

  • Nicotine resinate acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. By stimulating these receptors, it mimics the pharmacological effects of nicotine from tobacco, thereby alleviating withdrawal symptoms and reducing the urge to smoke. The controlled oromucosal delivery allows gradual tapering of nicotine exposure while maintaining receptor activation.

Side Effects

Niquitin Mint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Mouth irritation: mild soreness or tingling in the oral cavity.
  • Nausea: occasional feeling of queasiness.
  • Headache: mild to moderate head pain.
  • Dizziness: brief episodes of light‑headedness.
  • Increased salivation: excess saliva production.

Serious or Rare Side Effects

  • Allergic reaction: rash, itching, swelling, or difficulty breathing.
  • Cardiovascular events: chest pain or palpitations.
  • Severe nausea/vomiting: persistent and intense gastrointestinal upset.
  • Hypotension: unusually low blood pressure.
  • Throat ulceration: painful lesions in the throat.

Precautions & Warnings

Before using Niquitin Mint, consider the following precautions to ensure safe and effective use.

  • Assess medical history: disclose cardiovascular disease, diabetes, or gastrointestinal disorders.
  • Avoid use in children: not intended for individuals under the legal smoking age.
  • Monitor for dependence: prolonged use may lead to nicotine dependence on the product.
  • Caution with medications: discuss concurrent use of monoamine oxidase inhibitors or other nicotine‑containing products.
  • Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited.
  • Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Avoid Interactions

Niquitin Mint can interact with certain medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): concurrent use may increase risk of hypertensive crisis.
  • Other nicotine products: combined nicotine exposure can raise the likelihood of cardiovascular side effects.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs, SNRIs): may enhance nicotine’s effect on mood, requiring monitoring.
  • Antihypertensive drugs: nicotine can counteract blood‑pressure‑lowering effects.
  • Caffeine‑containing medications: nicotine may increase stimulant effects, leading to jitteriness.

Frequently Asked Questions

Niquitin Mint is an over‑the‑counter nicotine replacement product designed to help adults who smoke reduce cravings and manage withdrawal symptoms during a quit attempt. It delivers nicotine through the oral mucosa, providing a controlled dose that eases the transition away from combustible tobacco.

Nicotine resinate is an agonist at nicotinic acetylcholine receptors in the brain. By binding to these receptors, it reproduces many of nicotine’s pharmacologic actions, which reduces the intensity of withdrawal and the urge to smoke while allowing the user to taper nicotine exposure gradually.

The appropriate dose of Niquitin Mint is determined by a qualified healthcare professional based on the individual’s smoking history, level of dependence, and treatment goals. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for nicotine resinate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Niquitin Mint.

To request Niquitin Mint, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Niquitin Mint delivers nicotine via an oromucosal route, similar to nicotine gum or lozenges, but its mint formulation may improve palatability for some users. Compared with transdermal patches, it offers faster onset of action and more flexible dosing, allowing users to adjust intake based on cravings.

Store Niquitin Mint at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and keep it out of reach of children. Do not refrigerate or freeze the product.

Niquitin Mint is placed in the mouth and allowed to dissolve slowly, permitting nicotine absorption through the oral mucosa. Users should avoid chewing or swallowing the product whole and follow the administration instructions provided by their healthcare professional.

Serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and cardiovascular events like chest pain or palpitations. If any of these occur, discontinue use immediately and seek medical attention.

Individuals under the legal smoking age, those with known hypersensitivity to nicotine resinate or any excipients, and patients with uncontrolled cardiovascular disease should avoid using Niquitin Mint unless advised otherwise by a qualified healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine Resinate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT